Effect of probiotic Bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: Results of a 24-week randomized, double-blind, placebo-controlled trial

Manuscript Number: 

22-0148R1

Author(s): 
Heii Arai, Daisuke Asaoka, Francois Bernier, Yosuke Ichimiya, Noriko Katsumata, Shigeo Koido, Akihito Nagahara, Toshifumi Ohkusa, Kazuya Ohno, Nobuhiro Sato, Tsutomu Takeda, Jinzhong Xiao, Takahiro Yamazaki, Naotake Yanagisawa

Disclosures

Heii Arai

  • Consulting Fees:
    Advisor Consulting Fee: Morinaga Milk Co.Ltd $5,000/year
    Lecture Fees:
    Lecture　Daiichi-Sankyo Co.Ltd $1,000 Lecture Eisai Co.Ltd $800　
    Grants
    • Agency: 
      Morinaga Milk Co.Ltd
      Dates: 
      2021/04/01

Daisuke Asaoka

  • Nothing to Disclose

Francois Bernier

  • Sponsors:
    Senior Manager in the R&D division.

Yosuke Ichimiya

  • Nothing to Disclose

Noriko Katsumata

  • Sponsors:
    I am employed by Morinaga Milk Industry Co., Ltd, the supplier of the test food in this trial.

Shigeo Koido

  • Nothing to Disclose

Akihito Nagahara

  • Nothing to Disclose

Toshifumi Ohkusa

  • Nothing to Disclose

Kazuya Ohno

  • Nothing to Disclose

Nobuhiro Sato

  • Nothing to Disclose

Tsutomu Takeda

  • Nothing to Disclose

Jinzhong Xiao

  • Sponsors:
    I am employed by Morinaga Milk Industry Co., Ltd., the supplier of the test foods in this trial

Takahiro Yamazaki

  • Nothing to Disclose

Naotake Yanagisawa

  • Nothing to Disclose